mechanism of action glp-1 agonist Glucagon-like peptide-1 receptor: mechanisms and advances in therapy Frontiers | GLP-1 based therapeutics:

[7] who conducted a study to detect the risk of biliary-related diseases in patients with T2D using GLP-1RAs versus sodium glucose co-transporters 2 inhibitors (SGLT2I)

Their lucrative value in part reflects the fact that many studies are showing them to have therapeutic promise for several indications beyond type-2 diabetes and obesity (Manalac Dec 2024)

higher starch, sugar, or salt

Endocrinol Metab Clinics North Am

In another mouse model, a modified form of exenatide (NLY01) protected against the loss of dopaminergic neurons through the direct prevention of microglial-mediated conversion of astrocytes to a neurotoxic phenotype [45]